Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset Sepsis

NCT01551394 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

272

Enrollment

NETWORK

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Meropenem
DRUG: Ampicillin + gentamicin or cefotaxime + gentamicin

Sponsor

PENTA Foundation

Collaborators

[object Object]